Other Financial Statement Information - Schedule of Prepaid Expenses and Other Current Assets (Details) - USD ($) $ in Thousands |
Jun. 30, 2026 |
Dec. 31, 2025 |
|---|---|---|
| Other Financial Statement Information [Abstract] | ||
| Prepaid drug manufacturing costs | $ 9,978 | $ 1,637 |
| Interest income receivable | 3,928 | 3,285 |
| Prepaid clinical trial costs | 2,930 | 3,435 |
| Prepaid commercial planning costs | 2,562 | 359 |
| Prepaid software costs | 2,448 | 1,669 |
| Prepaid medical affairs costs | 2,277 | 486 |
| Other | 4,209 | 3,423 |
| Total prepaid expenses and other current assets | $ 28,332 | $ 14,294 |
| X | ||||||||||
- Definition Carrying amount as of the balance sheet date of interest earned but not received. Also called accrued interest or accrued interest receivable. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of current assets classified as other. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Other financial statement information. No definition available.
|
| X | ||||||||||
- Definition Prepaid clinical trial costs. No definition available.
|
| X | ||||||||||
- Definition Prepaid commercial costs. No definition available.
|
| X | ||||||||||
- Definition Prepaid drug manufacturing costs. No definition available.
|
| X | ||||||||||
- Definition Prepaid medical affairs. No definition available.
|
| X | ||||||||||
- Definition Prepaid Software Costs No definition available.
|